Applied DNA Sciences Inc. (NASDAQ: APDN), a biotechnology firm specializing in nucleic acid production, has announced commitments of up to $58 million in a private placement to launch a new digital asset treasury strategy focused on BNB, the native cryptocurrency of the Binance blockchain. The offering includes two concurrent private placements: a cash offering involving 4,730,178 shares of common stock (or prefunded warrants) and common warrants, and a cryptocurrency offering involving 3,334,471 prefunded warrants and common warrants. All warrants have an exercise price of $3.82 and a 5-year term. The capital raised will be used to acquire BNB, providing institutional and retail investors with exposure to the BNB blockchain and Binance ecosystem. Lucid Capital Markets acted as the sole placement agent for the transaction.